Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Peter Tsai

Thoracic Surgery (Cardiothoracic Vascular Surgery) Honolulu, HI Medical Doctor

NPI 1265684583 CMS profile 148604

550 S Beretania St Ste 702, Honolulu, HI 96813

Open in the dashboard

General payments

$51,258

391 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Peter Tsai of Honolulu, HI is reported in the CMS Open Payments database as having received $51,258 across 391 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,784 55
2024 General $7,358 63
2023 General $9,635 83
2022 General $11,990 71
2021 General $4,489 44
2020 General $784 11
2019 General $12,218 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Peter Tsai
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Peter Tsai were reported at $4,784. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Peter Tsai Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $12,218 $886 $178–$3,167 $163
2020 $784 $341 $108–$1,605 $114
2021 $4,489 $453 $125–$1,886 $132
2022 $11,990 $695 $180–$2,566 $149
2023 $9,635 $745 $205–$2,662 $160
2024 $7,358 $799 $214–$2,967 $164
2025 $4,784 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $9,699 68 payments
  2. Abiomed $8,806 48 payments
  3. KLS-Martin L.P. $5,014 23 payments
  4. CryoLife, Inc. $4,711 31 payments
  5. Medtronic, Inc. $4,570 50 payments
  6. Abbott Laboratories $4,241 38 payments
  7. Medtronic Vascular, Inc. $2,719 12 payments
  8. Edwards Lifesciences Corporation $2,077 18 payments
  9. Corcym Inc $1,897 17 payments
  10. Ethicon US, LLC $828 16 payments
  11. Other $6,698 70 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $34,598 330 payments
  2. Travel and Lodging $16,042 47 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $304 1 payment
  4. Education $163 12 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $151 1 payment
Products named General payments · program years 2019–2025
  1. Impella $8,365 43 payments
  2. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $4,334 29 payments
  3. ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER $3,010 20 payments
  4. HeartWare HVAD $2,594 11 payments
  5. ATRICLIP LAA EXCLUSION SYSTEM $2,329 20 payments
  6. Avalus $2,118 21 payments
  7. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $2,081 21 payments
  8. BIOGLUE SURGICAL ADHESIVE $1,897 19 payments
  9. PERCEVAL $1,897 17 payments
  10. CRYOVALVE SG PULMONARY HUMAN HEART VALVE $1,885 19 payments
  11. Other $20,709 215 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$51,452

Medicare's payments for the services billed

Medicare patients

99

Average age 75

Services billed

179

38 women, 61 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 69%
Ischemic heart disease 68%
Chronic kidney disease 54%
Diabetes 53%
Atrial fibrillation 42%
Arthritis 37%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • E.R. Squibb & Sons, L.L.C. $122
$122 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

391 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record